Related references
Note: Only part of the references are listed.The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw et al.
CLINICAL CANCER RESEARCH (2012)
Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth
Nikolai N. Khodarev et al.
CLINICAL CANCER RESEARCH (2012)
Regulation of COX2 Expression in Mouse Mammary Tumor Cells Controls Bone Metastasis and PGE2-Induction of Regulatory T Cell Migration
John Karavitis et al.
PLOS ONE (2012)
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Szeman Ruby Chan et al.
BREAST CANCER RESEARCH (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Mast Cell 5-Lipoxygenase Activity Promotes Intestinal Polyposis in APCΔ468 Mice
Eric C. Cheon et al.
CANCER RESEARCH (2011)
Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients
Diana L. Simons et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
Laura M. Hix et al.
PLOS ONE (2011)
Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation
T. Kaur et al.
CELL DEATH & DISEASE (2011)
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
Julia Schultz et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
N. Khodarev et al.
ONCOGENE (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
Immunosuppressive mechanisms in human tumors: Why we still cannot cure cancer
Stefanie Gross et al.
IMMUNOLOGY LETTERS (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis
Zhigang Li et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
Stephanie K. Bunt et al.
CANCER RESEARCH (2007)
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells
Nikolai N. Khodarev et al.
CANCER RESEARCH (2007)
Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma
Mahmood Manavi et al.
GYNECOLOGIC ONCOLOGY (2007)
Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma
Rebecca J. Critchley-Thorne et al.
PLOS MEDICINE (2007)
Effects of IFN-γ and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cells
Jiannong Li et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2007)
A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-γ in human cancer cells
Rebecca A. Lynch et al.
CANCER RESEARCH (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer
Martin Buess et al.
GENOME BIOLOGY (2007)
Regulatory T cells and cancer
Helen Y. Wang et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
Jack D. Bui et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
STAT1 acts as a tumor promoter for leukemia development
Boris Kovacic et al.
CANCER CELL (2006)
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer
K Khazaie et al.
SEMINARS IN CANCER BIOLOGY (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1β-secreting cells
XP Song et al.
JOURNAL OF IMMUNOLOGY (2005)
Tumor necrosis factor, cancer and anticancer therapy
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
STAT1 as a new molecular target of anti-inflammatory treatment
AC de Prati et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock
WJ Lin et al.
SHOCK (2005)
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells
NN Khodarev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
C Melani et al.
BLOOD (2003)
Mechanism of cyclooxygenase-2 upregulation in late preconditioning
YT Xuan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Distinct requirements for IFNs and STAT1 in NK cell function
CK Lee et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
